Yayınlanma: 30 Haziran 2020 20:14
Güncellenme: 7 Kasım 2024 13:51
Novavax today is trading at $83.61, it is trading higher with $6.22 amid catalysts including its COVID-19 vaccine program. Vernon Bernardino reiterated a top pick Buy rating on Novavax and raised the price target from $50 to $101. Novavax Analyst Says COVID-19 Vaccine Could Net $400M In Yearly Sales. He went on to say Novavax is capable of being a robust competitor against larger vaccine makers, likely helping it realize over $400 million in annual sales of NVX-CoV2373.